Jundishapur Journal of Microbiology

Published by: Kowsar

Challenges of Tuberculosis in Iran

Abed Zahedi Bialvaei 1 , Mohammad Asgharzadeh 2 , Mohammad Aghazadeh 1 , Manouchehr Nourazarian 3 and Hossein Samadi Kafil 3 , *
Authors Information
1 Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Drug Applied Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2017, 10 (3); e37866
  • Published Online: February 1, 2017
  • Article Type: Review Article
  • Received: April 21, 2016
  • Revised: January 12, 2017
  • Accepted: January 18, 2017
  • DOI: 10.5812/jjm.37866

To Cite: Zahedi Bialvaei A, Asgharzadeh M, Aghazadeh M, Nourazarian M, Samadi Kafil H. Challenges of Tuberculosis in Iran, Jundishapur J Microbiol. 2017 ; 10(3):e37866. doi: 10.5812/jjm.37866.

Abstract
Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Evidence Acquisition
4. General Status of Tuberculosis in Iran
5. Incidence and Prevalence
6. Tuberculosis Incidence Rates by Sex and Age
7. Molecular Typing of M. tuberculosis in the Population
8. Immigrants
9. Treatment Policy and Antibiotic Resistance
10. Multidrug-Resistant Tuberculosis in Iran
11. Surveillance System
12. Tuberculosis in People with AIDS
13. Conclusions
Acknowledgements
Footnotes
References
  • 1. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. 2007;
  • 2. Tabassum Siddiqui R, Waheed Akhtar M, Anver Qureshi J. The Presence and Copy Number of Insertion Sequence IS6110 in Mycobacterium tuberculosis Isolates from Pakistan. Int J Agric Biol. 2013; 15(3)
  • 3. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003; 16(3): 463-96[PubMed]
  • 4. Khazaei HA, Rezaei N, Bagheri GR, Dankoub MA, Shahryari K, Tahai A, et al. Epidemiology of tuberculosis in the Southeastern Iran. Eur J Epidemiol. 2005; 20(10): 879-83[DOI][PubMed]
  • 5. Palwatwichai A. Tuberculosis in Thailand. Respirology. 2001; 6(1): 65-70[PubMed]
  • 6. Tavakoli A, Safaee HG, Navvabakbar F, Salehi M, Bahremand A, Isfahani BN. Mutations in the rpoB Gene of Rifampin Resistant Myco-bacterium tuberculosis Isolated in Isfahan by PCR-SSCP. J Sci. 2005; 16(2): 131-8
  • 7. WHO . Global tuberculosis report 2012. 2012;
  • 8. Tuberculosis Facts, 2009 Update. 2009;
  • 9. Global health observatory data repository 2011. 2011;
  • 10. Babamahmoodi F, Alikhani A, Yazdani Charati J, Ghovvati A, Ahangarkani F, Delavarian L, et al. Clinical epidemiology and paraclinical findings in tuberculosis patients in north of Iran. Biomed Res Int. 2015; 2015: 381572[DOI][PubMed]
  • 11. Global Tuberculosis Report 2013. 2013;
  • 12. Ayatollahi J, Sharifi MR, Razmi H, Mahmoodiardekani B. The survey of tuberculosis patients in Yazd and Shiraz. Q Res J Yazd. 2010; 9(1): 1-7
  • 13. Filliol I, Driscoll JR, Van Soolingen D, Kreiswirth BN, Kremer K, Valetudie G, et al. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis. 2002; 8(11): 1347-9[DOI][PubMed]
  • 14. Ramazanzadeh R, Sayhemiri K. Prevalence of Beijing family in Mycobacterium tuberculosis in world population: Systematic Review and Meta-Analysis. Int J Mycobacteriol. 2014; 3(1): 41-5[DOI][PubMed]
  • 15. Merza MA, Farnia P, Salih AM, Masjedi MR, Velayati AA. First insight into the drug resistance pattern of Mycobacterium tuberculosis in Dohuk, Iraq: using spoligotyping and MIRU-VNTR to characterize multidrug resistant strains. J Infect Public Health. 2011; 4(1): 41-7[DOI][PubMed]
  • 16. Farnia P, Masjedi MR, Mirsaeidi M, Mohammadi F, Jallaledin G, Vincent V, et al. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J Infect. 2006; 53(5): 331-6[DOI][PubMed]
  • 17. Doustdar F, Khosravi AD, Farnia P, Bahrmand AR, Masjedi MR, Velayati AA. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos. 2008; 7(2): 11-7
  • 18. Doroudchi M, Kremer K, Basiri EA, Kadivar MR, Van Soolingen D, Ghaderi AA. IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scand J Infect Dis. 2000; 32(6): 663-8[PubMed]
  • 19. Bialvaei AZ, Kafil HS, Asgharzadeh M. Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran. Clin Infect Dis. 2015; 61(6): 1029-30[DOI][PubMed]
  • 20. Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, Ghebremicheal S, et al. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis. 2008; 8: 171[DOI][PubMed]
  • 21. Velayati AA, Farnia P, Mirsaeidi M, Reza Masjedi M. The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases. Scand J Infect Dis. 2006; 38(6-7): 463-8[DOI][PubMed]
  • 22. Global tuberculosis control: surveillance, planning, financing. 2003;
  • 23. Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, et al. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Int J Infect Dis. 2009; 13(5)-40[DOI][PubMed]
  • 24. Farnia P, Masjedi MR, Varahram M, Mirsaeidi M, Ahmadi M, Khazampour M, et al. The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping. BMC Infect Dis. 2008; 8: 109[DOI][PubMed]
  • 25. Asgharzadeh M, Kafil HS, Pourostadi M. Limited transmission of multidrug-resistant tuberculosis in East Azarbaijan, Iran. Beni Suef Univ J Basic Appl Sci. 2014; 3(4): 254-9[DOI]
  • 26. Asgharzadeh M, Shahbabian K, Samadi Kafil H, Rafi A. Use of DNA Fingerprinting in Identifying the Source Case of Tuberculosis in East Azarbaijan Province of Iran. J Med Sci (Faisalabad). 2007; 7(3): 418-21[DOI]
  • 27. Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR, Velayati AA. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis. J Infect Dev Ctries. 2011; 5(7): 511-9[PubMed]
  • 28. Velayati AA. Tuberculosis guide. 1996;
  • 29. Masjedi MR, Tabatabaii D, Salek S. Tuberculosis guide. 1997;
  • 30. Bahrmand AR, Velayati AA, Bakayev VV. Treatment monitoring and prevalence of drug resistance in tuberculosis patients in Tehran. Int J Tuberc Lung Dis. 2000; 4(6): 544-9[PubMed]
  • 31. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CJ. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993; 328(8): 527-32[DOI][PubMed]
  • 32. Valenzuela P, Valenzuela MT, Ponce J. Response to short-course chemotherapy of patients with initial resistance to antituberculosis drugs. Bull Pan Am Health Organ. 1988; 22(2): 175-83[PubMed]
  • 33. Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol. 1998; 36(1): 20-3[PubMed]
  • 34. Spindola de Miranda S, Kritski A, Filliol I, Mabilat C, Panteix G, Drouet E. Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France. Mem Inst Oswaldo Cruz. 2001; 96(2): 247-50[PubMed]
  • 35. McCammon MT, Gillette JS, Thomas DP, Ramaswamy SV, Graviss EA, Kreiswirth BN, et al. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob Agents Chemother. 2005; 49(6): 2200-9[DOI][PubMed]
  • 36. Mohajeri P, Sadri H, Farahani A, Norozi B, Atashi S. Frequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran. Microb Drug Resist. 2015; 21(3): 315-9[DOI][PubMed]
  • 37. Kim BJ, Hong SK, Lee KH, Yun YJ, Kim EC, Park YG, et al. Differential identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria by duplex PCR assay using the RNA polymerase gene (rpoB). J Clin Microbiol. 2004; 42(3): 1308-12[PubMed]
  • 38. Ormerod LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull. 2005; 73-74: 17-24[DOI][PubMed]
  • 39. Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, et al. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. Int J Infect Dis. 2005; 9(6): 317-22[DOI][PubMed]
  • 40. Nasiri MJ, Rezaei F, Zamani S, Darban-Sarokhalil D, Fooladi AA, Shojaei H, et al. Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran. Asian Pac J Trop Med. 2014; 7(3): 193-6[DOI][PubMed]
  • 41. Ramazanzadeh R, Farnia P, Amirmozafari N, Ghazi F, Ghadertotonchi Z, Kamran J, et al. Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients. Chemotherapy. 2006; 52(6): 316-20[DOI][PubMed]
  • 42. Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol. 2006; 62(5): 1220-7[DOI][PubMed]
  • 43. Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, Foxman B, et al. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn Microbiol Infect Dis. 2005; 53(3): 201-8[DOI][PubMed]
  • 44. Hristea A, Otelea D, Paraschiv S, Macri A, Baicus C, Moldovan O, et al. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR. Indian J Med Microbiol. 2010; 28(3): 211-6[DOI][PubMed]
  • 45. Guo H, Seet Q, Denkin S, Parsons L, Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol. 2006; 55: 1527-31[DOI][PubMed]
  • 46. Mirsaeidi MS, Tabarsi P, Farnia P, Ebrahimi G, Morris MW, Masjedi MR, et al. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran. Saudi Med J. 2007; 28(4): 544-50[PubMed]
  • 47. Zaker Bostanabad S, Fateh A, Seyedi K, Abdolrahimi F, Karimi A, Hadizadeh Tasbiti A, et al. Frequency and molecular characterization of rifampicin-resistance in rpoB region of multiple drug resistance (MDR) isolates from tuberculosis patients in southern endemic region of Iran. Iran J Biotechnol. 2007; 5(4): 212-8
  • 48. Mohajeri P, Tavakoli A, Moghim S. Detection of mutation in codon 315 katG gene as a gene marker associated with isoniazid resistance, in mycobacterium tuberculosis strains isolated from patients in Isfahan and Tehran by PCR-RFLP method. ZUMS J. 2009; 17(66): 29-40
  • 49. Heifets L, Lindholm-Levy P. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am Rev Respir Dis. 1992; 145(5): 1223-5[DOI][PubMed]
  • 50. Mitchison DA. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 1985; 66(3): 219-25[PubMed]
  • 51. Marttila HJ, Marjamaki M, Vyshnevskaya E, Vyshnevskiy BI, Otten TF, Vasilyef AV, et al. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia. Antimicrob Agents Chemother. 1999; 43(7): 1764-6[PubMed]
  • 52. Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965; 92(5): 687-703[DOI][PubMed]
  • 53. The WHO/IUATLD global project to anti-tuberculosis drug resistance surveillance 2000. 2000;
  • 54. Baran R, Ertan FU, Ozvaran K, Dolunay G. Primary drug resistant tuberculosis in children: A report from Turkey. Tubercle Lung Dis. 1994; 75: 12[DOI]
  • 55. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis. 2001; 5(10): 887-93[PubMed]
  • 56. Namaei MH, Sadeghian A, Naderinasab M, Ziaee M. Prevalence of primary drug resistant Mycobacterium tuberculosis in Mashhad, Iran. Indian J Med Res. 2006; 124(1): 77-80[PubMed]
  • 57. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2000; 4(2): 108-14[PubMed]
  • 58. Bostanabad SZ, Bahrmand A, Titov LP, Taghikhani M. Identification of mutations in the rpoB encoding the RNA polymerase beta subunit in rifampicine-resistant Mycobacterium tuberculosis strains from Iran. Tuberk Toraks. 2007; 55(4): 370-7[PubMed]
  • 59. Marjani M, Baghaei P, Tabarsi P, Shamaei M, Mansouri D, Masjedi MR, et al. Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis. East Mediterr Health J. 2012; 18(9): 957-61[PubMed]
  • 60. Surucuoglu S, Ozkutuk N, Celik P, Gazi H, Dinc G, Kurutepe S, et al. Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Ann Saudi Med. 2005; 25(4): 313-8[PubMed]
  • 61. Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis. 2006; 43(7): 841-7[DOI][PubMed]
  • 62. Asgharzadeh M, Kafil HS, Roudsary AA, Hanifi GR. Tuberculosis transmission in Northwest of Iran: using MIRU-VNTR, ETR-VNTR and IS6110-RFLP methods. Infect Genet Evol. 2011; 11(1): 124-31[DOI][PubMed]
  • 63. Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015; 31(4): 707-21[DOI][PubMed]
  • 64. Lonnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med. 2008; 29(5): 481-91[DOI][PubMed]
  • 65. Diagnostic and Treatment Delay in Tuberculosis, 2006. 2006;
  • 66. Bai Y, Xue Y, Gao H, Wang L, Ding T, Bai W, et al. Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model. Protein Expr Purif. 2008; 59(2): 189-96[DOI][PubMed]
  • 67. Hadadi A, Rasoolinejad M, Davoudi S, Nikdel M, Rasteh M. Clinical characteristics of pulmonary tuberculosis in patients with HIV/AIDS: a case-control study. Tehran Univ Med J TUMS Public. 2006; 64(5): 87-95
  • 68. Converse PJ, Jones SL, Astemborski J, Vlahov D, Graham NM. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis. 1997; 176(1): 144-50[PubMed]
  • 69. Asgharzadeh M, Kafil HS, Khakpour M. Comparison of mycobacterial interspersed repetitive unit-variable number tandem repeat and IS6110-RFLP methods in identifying epidemiological links in patients with tuberculosis in Northwest of Iran. Ann Microbiol. 2008; 58: 333[DOI]
  • 70. Asgharzadeh M, Samadi Kafil H. Current trends in molecular epidemiology studies of Mycobacterium tuberculosis. Biotechnol Mol Biol Rev. 2007; 2(5): 108-15
  • 71. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Garcia I, Cabrera P, et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med. 2001; 164(7): 1165-70[DOI][PubMed]
  • 72. Asgharzadeh M, Yousefee S, Nahaei MR, Akhi MT, Ansarian K, Samadi Kafil H. IS6110 Fingerprinting of Mycobacterium tuberculosis Strains Isolated from Northwest of Iran. Res J Microbiol. 2007; 2(12): 940-6[DOI]
  • 73. Magdalena J, Vachee A, Supply P, Locht C. Identification of a new DNA region specific for members of Mycobacterium tuberculosis complex. J Clin Microbiol. 1998; 36(4): 937-43[PubMed]
  • 74. Chaves F, Yang Z, el Hajj H, Alonso M, Burman WJ, Eisenach KD, et al. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol. 1996; 34(5): 1118-23[PubMed]
  • 75. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997; 35(4): 907-14[PubMed]
  • 76. Mazars E, Lesjean S, Banuls AL, Gilbert M, Vincent V, Gicquel B, et al. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A. 2001; 98(4): 1901-6[DOI][PubMed]
  • 77. Swaminathan S, Narendran G. HIV and tuberculosis in India. J Biosci. 2008; 33(4): 527[DOI]
  • 78. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999; 282(7): 677-86[PubMed]
  • 79. Jam S, Sabzvari D, SeyedAlinaghi S, Fattahi F, Jabbari H, Mohraz M. Frequency of Mycobacterium tuberculosis infection among Iranian patients with HIV/AIDS by PPD test. Acta Med Iran. 2010; 48(1): 67-71[PubMed]
  • 80. Tabarsi P, Mirsaeidi SM, Amiri M, Mansouri SD, Masjedi MR, Velayati AA. Clinical and laboratory profile of patients with tuberculosis/HIV coinfection at a national referral centre: a case series. East Mediterr Health J. 2008; 14(2): 283-91[PubMed]
  • 81. Mansoori D, Alaei K, Alaei A. Prevalence of clinical tuberculosis in HIV infected patients from Kermanshah Province, Iran. Tanaffos. 2002; 1(2): 27-33
  • 82. Khosravi AD, Alavi SM, Hashemzade M, Abasi E, Seghatoleslami S. The relative frequency of Mycobacterium tuberculosis and Mycobacterium avium infections in HIV positive patients, Ahvaz, Iran. Asian Pac J Trop Med. 2012; 5(1): 71-4[DOI][PubMed]
  • 83. Steinbrook R. Tuberculosis and HIV in India. N Engl J Med. 2007; 356(12): 1198-9[DOI][PubMed]
  • 84. Dye C. Global epidemiology of tuberculosis. Lancet. 2006; 367(9514): 938-40[DOI]
  • 85. Asgharzadeh M, Samadi Kafil H, Pourostadi M, Asadi Faezi N, Rashedi J, Mahdavipour B. Strain differentiation of Mycobacterium tuberculosis for epidemiology in northwest of Iran. Cell Mol Biol (Noisy-le-grand). 2016; 62(8): 15-20[PubMed]
  • 86. Pourostadi M, Rashedi J, Mahdavi Poor B, Samadi Kafil H, Shirazi S, Asgharzadeh M. Molecular Diversity of Mycobacterium tuberculosis Strains in Northwestern Iran. Jundishapur J Microbiol. 2016; 9(9)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments